1887

Abstract

Ten carbapenem-resistant (eight isolates and two ) isolates from Yemen were investigated using antimicrobial susceptibility testing, phenotypic carbapenemase detection, multilocus sequence typing (MLST) and replicon typing. Carbapenemase, extended-spectrum β-lactamase (ESBL) and plasmid-mediated quinolone resistance determinant genes were identified using PCR and sequencing. All of the 10 carbapenem-resistant were resistant to β-lactams, tobramycin, ciprofloxacin and cotrimoxazole. Imipenem, doripenem and meropenem MICs ranged from 2 to >32 mg l and ertapenem MICs ranged from 6 to >32 mg l. All of the isolates showed ESBL activity in phenotypic tests. Genes encoding were detected in all strains. All strains produced CTX-M-15 ESBL and SHV β-lactamases. TEM-1 β-lactamase was detected in seven isolates. Nine isolates were positive including QnrB1, QnrA1 and QnrS1, and six isolates produced AAC-6′-Ib-cr. MLST identified five different sequence types (STs): ST1399, ST147, ST29, ST405 and ST340. Replicon typing showed the presence of IncFII1K plasmids in four transformants. To the best of our knowledge, this is the first report of NDM-1-producing isolates in Yemen.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.073767-0
2014-10-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/63/10/1316.html?itemId=/content/journal/jmm/10.1099/jmm.0.073767-0&mimeType=html&fmt=ahah

References

  1. Abdelaziz M. O., Bonura C., Aleo A., Fasciana T., Mammina C. 2013; NDM-1- and OXA-163-producing Klebsiella pneumoniae isolates in Cairo, Egypt. J Glob Antimicrob Resist 1:213–215 [View Article]
    [Google Scholar]
  2. Al-Agamy M. H., Shibl A. M., Tawfik A. F. 2009; Prevalence and molecular characterization of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia. Ann Saudi Med 29:253–257 [View Article][PubMed]
    [Google Scholar]
  3. Al-Agamy M. H., Shibl A. M., Elkhizzi N. A., Meunier D., Turton J. F., Livermore D. M. 2013; Persistence of Klebsiella pneumoniae clones with OXA-48 or NDM carbapenemases causing bacteraemias in a Riyadh hospital. Diagn Microbiol Infect Dis 76:214–216 [View Article][PubMed]
    [Google Scholar]
  4. Al-Shamahy H. A., Sabrah A. A., Al-Robasi A. B., Naser S. M. 2012; Types of bacteria associated with neonatal sepsis in Al-Thawra University Hospital, Sana’a, Yemen and their antimicrobial profile. Sultan Qaboos Univ Med J 12:48–54[PubMed] [CrossRef]
    [Google Scholar]
  5. Alfaresi M. S., Elkoush A. A., Alshehhi H. M., Abdulsalam A. I. 2011; Molecular characterization and epidemiology of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in the United Arab Emirates. Med Princ Pract 20:177–180 [View Article][PubMed]
    [Google Scholar]
  6. Arpin C., Noury P., Boraud D., Coulange L., Manetti A., André C., M’Zali F., Quentin C. 2012; NDM-1-producing Klebsiella pneumoniae resistant to colistin in a French community patient without history of foreign travel. Antimicrob Agents Chemother 56:3432–3434 [View Article][PubMed]
    [Google Scholar]
  7. Asghar A. H. 2006; Frequency and antimicrobial susceptibility patterns of bacterial pathogens isolated from septicemic patients in Makkah hospitals. Saudi Med J 27:361–367[PubMed]
    [Google Scholar]
  8. Bakour S., Alsharapy S. A., Touati A., Rolain J. M. 2014; Characterization of Acinetobacter baumannii Clinical Isolates Carrying blaOXA-23 Carbapenemase and 16S rRNA Methylase armA genes in Yemen. Microb Drug Resist [Epub ahead of print] [View Article][PubMed]
    [Google Scholar]
  9. Bogaerts P., Bouchahrouf W., de Castro R. R., Deplano A., Berhin C., Piérard D., Denis O., Glupczynski Y. 2011; Emergence of NDM-1-producing Enterobacteriaceae in Belgium. Antimicrob Agents Chemother 55:3036–3038 [View Article][PubMed]
    [Google Scholar]
  10. Bonnin R. A., Poirel L., Carattoli A., Nordmann P. 2012; Characterization of an IncFII plasmid encoding NDM-1 from Escherichia coli ST131. PLoS ONE 7:e34752 [View Article][PubMed]
    [Google Scholar]
  11. Cantón R., Akóva M., Carmeli Y., Giske C. G., Glupczynski Y., Gniadkowski M., Livermore D. M., Miriagou V., Naas T. other authors 2012; Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 18:413–431 [View Article][PubMed]
    [Google Scholar]
  12. Carattoli A., Bertini A., Villa L., Falbo V., Hopkins K. L., Threlfall E. J. 2005; Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 63:219–228 [View Article][PubMed]
    [Google Scholar]
  13. Castanheira M., Deshpande L. M., Farrell S. E., Shetye S., Shah N., Jones R. N. 2013; Update on the prevalence and genetic characterization of NDM-1-producing Enterobacteriaceae in Indian hospitals during 2010. Diagn Microbiol Infect Dis 75:210–213 [View Article][PubMed]
    [Google Scholar]
  14. Chanal C., Bonnet R., De Champs C., Sirot D., Labia R., Sirot J. 2000; Prevalence of β-lactamases among 1,072 clinical strains of Proteus mirabilis: a 2-year survey in a French hospital. Antimicrob Agents Chemother 44:1930–1935 [View Article][PubMed]
    [Google Scholar]
  15. CLSI (2012). Performance Standards for Antimicrobial Susceptibility Testing: 22nd informational supplement. CLSI document M100–S22. Wayne, PA: Clinical Laboratory Standards Institute
  16. Dallenne C., Da Costa A., Decré D., Favier C., Arlet G. 2010; Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae . J Antimicrob Chemother 65:490–495 [View Article][PubMed]
    [Google Scholar]
  17. Diancourt L., Passet V., Verhoef J., Grimont P. A., Brisse S. 2005; Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 43:4178–4182 [View Article][PubMed]
    [Google Scholar]
  18. Dutour C., Bonnet R., Marchandin H., Boyer M., Chanal C., Sirot D., Sirot J. 2002; CTX-M-1, CTX-M-3, and CTX-M-14 β-lactamases from Enterobacteriaceae isolated in France. Antimicrob Agents Chemother 46:534–537 [View Article][PubMed]
    [Google Scholar]
  19. Ensor V. M., Jamal W., Rotimi V. O., Evans J. T., Hawkey P. M. 2009; Predominance of CTX-M-15 extended spectrum β-lactamases in diverse Escherichia coli and Klebsiella pneumoniae from hospital and community patients in Kuwait. Int J Antimicrob Agents 33:487–489 [View Article][PubMed]
    [Google Scholar]
  20. EUCAST (2014). Clinical breakpoints v.4.0. European Committee on Antimicrobial Susceptibility Testing http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/Breakpoint_table_v_4.0.pdf
  21. García-Fernández A., Fortini D., Veldman K., Mevius D., Carattoli A. 2009; Characterization of plasmids harbouring qnrS1, qnrB2 and qnrB19 genes in Salmonella . J Antimicrob Chemother 63:274–281 [View Article][PubMed]
    [Google Scholar]
  22. Ghazawi A., Sonnevend A., Bonnin R. A., Poirel L., Nordmann P., Hashmey R., Rizvi T. A., B Hamadeh M., Pál T. 2012; NDM-2 carbapenemase-producing Acinetobacter baumannii in the United Arab Emirates. Clin Microbiol Infect 18:E34–E36 [View Article][PubMed]
    [Google Scholar]
  23. Guillard T., Duval V., Moret H., Brasme L., Vernet-Garnier V., de Champs C. 2010; Rapid detection of aac(6′)-Ib-cr quinolone resistance gene by pyrosequencing. J Clin Microbiol 48:286–289 [View Article][PubMed]
    [Google Scholar]
  24. Guillard T., Moret H., Brasme L., Carlier A., Vernet-Garnier V., Cambau E., de Champs C. 2011; Rapid detection of qnr and qepA plasmid-mediated quinolone resistance genes using real-time PCR. Diagn Microbiol Infect Dis 70:253–259 [View Article][PubMed]
    [Google Scholar]
  25. Guillard T., Grillon A., de Champs C., Cartier C., Madoux J., Berçot B., Lebreil A. L., Lozniewski A., Riahi J. other authors 2014; Mobile insertion cassette elements found in small non-transmissible plasmids in Proteeae may explain qnrD mobilization. PLoS ONE 9:e87801 [View Article][PubMed]
    [Google Scholar]
  26. Islam M. A., Talukdar P. K., Hoque A., Huq M., Nabi A., Ahmed D., Talukder K. A., Pietroni M. A. C., Hays J. P. other authors 2012; Emergence of multidrug-resistant NDM-1-producing Gram-negative bacteria in Bangladesh. Eur J Clin Microbiol Infect Dis 31:2593–2600 [View Article][PubMed]
    [Google Scholar]
  27. Jamal W., Rotimi V. O., Albert M. J., Khodakhast F., Udo E. E., Poirel L. 2012; Emergence of nosocomial New Delhi metallo-β-lactamase-1 (NDM-1)-producing Klebsiella pneumoniae in patients admitted to a tertiary care hospital in Kuwait. Int J Antimicrob Agents 39:183–184 [View Article][PubMed]
    [Google Scholar]
  28. Kermas R., Touati A., Brasme L., Le Magrex-Debar E., Mehrane S., Weill F. X., De Champs C. 2012; Characterization of extended-spectrum β-lactamase-producing Salmonella enterica serotype Brunei and Heidelberg at the Hussein Dey hospital in Algiers (Algeria). Foodborne Pathog Dis 9:803–808 [View Article][PubMed]
    [Google Scholar]
  29. Khan A. U., Nordmann P. 2012; NDM-1-producing Enterobacter cloacae and Klebsiella pneumoniae from diabetic foot ulcers in India. J Med Microbiol 61:454–456 [View Article][PubMed]
    [Google Scholar]
  30. Kim M. N., Yong D., An D., Chung H. S., Woo J. H., Lee K., Chong Y. 2012; Nosocomial clustering of NDM-1-producing Klebsiella pneumoniae sequence type 340 strains in four patients at a South Korean tertiary care hospital. J Clin Microbiol 50:1433–1436 [View Article][PubMed]
    [Google Scholar]
  31. Kumarasamy K. K., Toleman M. A., Walsh T. R., Bagaria J., Butt F., Balakrishnan R., Chaudhary U., Doumith M., Giske C. G. other authors 2010; Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10:597–602 [View Article][PubMed]
    [Google Scholar]
  32. Leavitt A., Carmeli Y., Chmelnitsky I., Goren M. G., Ofek I., Navon-Venezia S. 2010; Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel. Antimicrob Agents Chemother 54:3002–3006 [View Article][PubMed]
    [Google Scholar]
  33. Memish Z. A. 2010; The Hajj: communicable and non-communicable health hazards and current guidance for pilgrims. Euro Surveill 15:19671[PubMed]
    [Google Scholar]
  34. Muir A., Weinbren M. J. 2010; New Delhi metallo-β-lactamase: a cautionary tale. J Hosp Infect 75:239–240 [View Article][PubMed]
    [Google Scholar]
  35. Nordmann P., Naas T., Poirel L. 2011; Global spread of carbapenemase-producing Enterobacteriaceae. . Emerg Infect Dis 17:1791–1798 [View Article][PubMed]
    [Google Scholar]
  36. Oteo J., Hernández J. M., Espasa M., Fleites A., Sáez D., Bautista V., Pérez-Vázquez M., Fernández-García M. D., Delgado-Iribarren A. other authors 2013; Emergence of OXA-48-producing Klebsiella pneumoniae and the novel carbapenemases OXA-244 and OXA-245 in Spain. J Antimicrob Chemother 68:317–321 [View Article][PubMed]
    [Google Scholar]
  37. Patel G., Bonomo R. A. 2013; “Stormy waters ahead”: global emergence of carbapenemases. Front Microbiol 4:48 [View Article][PubMed]
    [Google Scholar]
  38. Peirano G., Pillai D. R., Pitondo-Silva A., Richardson D., Pitout J. D. 2011; The characteristics of NDM-producing Klebsiella pneumoniae from Canada. Diagn Microbiol Infect Dis 71:106–109 [View Article][PubMed]
    [Google Scholar]
  39. Peirano G., Ahmed-Bentley J., Fuller J., Rubin J. E., Pitout J. D. 2014; Travel-related carbapenemase-producing Gram-negative bacteria in Alberta, Canada: the first 3 years. J Clin Microbiol 52:1575–1581 [View Article][PubMed]
    [Google Scholar]
  40. Poirel L., Le Thomas I., Naas T., Karim A., Nordmann P. 2000; Biochemical sequence analyses of GES-1, a novel class A extended-spectrum β-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae . Antimicrob Agents Chemother 44:622–632 [View Article][PubMed]
    [Google Scholar]
  41. Poirel L., Al Maskari Z., Al Rashdi F., Bernabeu S., Nordmann P. 2011a; NDM-1-producing Klebsiella pneumoniae isolated in the Sultanate of Oman. J Antimicrob Chemother 66:304–306 [View Article][PubMed]
    [Google Scholar]
  42. Poirel L., Fortineau N., Nordmann P. 2011b; International transfer of NDM-1-producing Klebsiella pneumoniae from Iraq to France. Antimicrob Agents Chemother 55:1821–1822 [View Article][PubMed]
    [Google Scholar]
  43. Poirel L., Benouda A., Hays C., Nordmann P. 2011c; Emergence of NDM-1-producing Klebsiella pneumoniae in Morocco. J Antimicrob Chemother 66:2781–2783 [View Article][PubMed]
    [Google Scholar]
  44. Poirel L., Bonnin R. A., Nordmann P. 2012; Genetic features of the widespread plasmid coding for the carbapenemase OXA-48. Antimicrob Agents Chemother 56:559–562 [View Article][PubMed]
    [Google Scholar]
  45. Rotimi V. O., Jamal W., Pal T., Sovenned A., Albert M. J. 2008; Emergence of CTX-M-15 type extended-spectrum β-lactamase-producing Salmonella spp. in Kuwait and the United Arab Emirates. J Med Microbiol 57:881–886 [View Article][PubMed]
    [Google Scholar]
  46. Shibl A. M., Al-Agamy M. H., Memish Z., Senok A., Khader S. A., Assiri A. 2013; The emergence of OXA-48- and NDM-1-positive Klebsiella pneumoniae in Riyadh, Saudi Arabia. Int J Infect Dis 17:e1130–e1133 [View Article][PubMed]
    [Google Scholar]
  47. Shoma S., Kamruzzaman M., Ginn A. N., Iredell J. R., Partridge S. R. 2014; Characterization of multidrug-resistant Klebsiella pneumoniae from Australia carrying bla NDM-1 . Diagn Microbiol Infect Dis 78:93–97 [View Article][PubMed]
    [Google Scholar]
  48. Sidjabat H., Nimmo G. R., Walsh T. R., Binotto E., Htin A., Hayashi Y., Li J., Nation R. L., George N., Paterson D. L. 2011; Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi metallo-β-lactamase. Clin Infect Dis 52:481–484 [View Article][PubMed]
    [Google Scholar]
  49. Teo J. W. P., Tan P., La M. V., Krishnan P., Tee N., Hsien K. T., Deepak N. R., Yen T. T., Jureen R., Lin R. T. P. 2014; Surveillance trends of carbapenem-resistant Enterobacteriaceae from Singapore, 2010–2013. J Glob Antimicrob Resist 2:99–102 [View Article]
    [Google Scholar]
  50. Wang X., Xu X., Li Z., Chen H., Wang Q., Yang P., Zhao C., Ni M., Wang H. 2014; An outbreak of a nosocomial NDM-1-producing Klebsiella pneumoniae ST147 at a teaching hospital in mainland China. Microb Drug Resist 20:144–149 [View Article][PubMed]
    [Google Scholar]
  51. Yong D., Lee K., Yum J. H., Shin H. B., Rossolini G. M., Chong Y. 2002; Imipenem-EDTA disk method for differentiation of metallo-β-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 40:3798–3801 [View Article][PubMed]
    [Google Scholar]
  52. Yong D., Toleman M. A., Giske C. G., Cho H. S., Sundman K., Lee K., Walsh T. R. 2009; Characterization of a new metallo-β-lactamase gene, bla NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 53:5046–5054 [View Article][PubMed]
    [Google Scholar]
  53. Zowawi H. M., Sartor A. L., Balkhy H. H., Walsh T. R., Al Johani S. M., AlJindan R. Y., Alfaresi M., Ibrahim E., Al-Jardani A. other authors 2014; Molecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the countries of the Gulf Cooperation Council: dominance of OXA-48 and NDM producers.. Antimicrob Agents Chemother 58:3085–3090 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.073767-0
Loading
/content/journal/jmm/10.1099/jmm.0.073767-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error